Finally, expression of pathways involved with insulin signaling and type II diabetes mellitus were increased with rapamycin treatment, further confirming the important role of mTOR in regulating glucose metabolism and insulin sensitivity. The gene discussed is INS; the disease is type 2 diabetes mellitus.